S. Civriz Et Al. , "Treatment of relapse after allogeneic stem cell transplantation in CML patients: Imatinib only vs imatinib&DLI," 12th Congress of the European-Hematology-Association , vol.92, Vienna, Austria, pp.487, 2007
Civriz, S. Et Al. 2007. Treatment of relapse after allogeneic stem cell transplantation in CML patients: Imatinib only vs imatinib&DLI. 12th Congress of the European-Hematology-Association , (Vienna, Austria), 487.
Civriz, S., CİVRİZ BOZDAĞ, S., Soydan, E., Topcuoglu, P., Bilgin, A. U., Bakanay, S., ... Koc, H.(2007). Treatment of relapse after allogeneic stem cell transplantation in CML patients: Imatinib only vs imatinib&DLI . 12th Congress of the European-Hematology-Association (pp.487). Vienna, Austria
Civriz, S. Et Al. "Treatment of relapse after allogeneic stem cell transplantation in CML patients: Imatinib only vs imatinib&DLI," 12th Congress of the European-Hematology-Association, Vienna, Austria, 2007
Civriz, S. Et Al. "Treatment of relapse after allogeneic stem cell transplantation in CML patients: Imatinib only vs imatinib&DLI." 12th Congress of the European-Hematology-Association , Vienna, Austria, pp.487, 2007
Civriz, S. Et Al. (2007) . "Treatment of relapse after allogeneic stem cell transplantation in CML patients: Imatinib only vs imatinib&DLI." 12th Congress of the European-Hematology-Association , Vienna, Austria, p.487.
@conferencepaper{conferencepaper, author={S. Civriz Et Al. }, title={Treatment of relapse after allogeneic stem cell transplantation in CML patients: Imatinib only vs imatinib&DLI}, congress name={12th Congress of the European-Hematology-Association}, city={Vienna}, country={Austria}, year={2007}, pages={487} }